In last trading session, Sana Biotechnology Inc. (NASDAQ:SANA) saw 2.19 million shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level of $4.47 trading at -$0.04 or -0.78% at ring of the bell on the day assigns it a market valuation of $885.15M. That closing price of SANA’s stock is at a discount of -79.19% from its 52-week high price of $8.01 and is indicating a premium of 33.11% from its 52-week low price of $2.99. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.19 million shares which gives us an average trading volume of 978.48K if we extend that period to 3-months.
For Sana Biotechnology Inc. (SANA), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.30. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.44 in the current quarter.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
Sana Biotechnology Inc. (NASDAQ:SANA) trade information
Upright in the red during last session for losing -0.78%, in the last five days SANA remained trading in the red while hitting it’s week-highest on Tuesday, 09/12/23 when the stock touched $4.47 price level, adding 22.66% to its value on the day. Sana Biotechnology Inc.’s shares saw a change of 13.16% in year-to-date performance and have moved -18.87% in past 5-day. Sana Biotechnology Inc. (NASDAQ:SANA) showed a performance of -16.91% in past 30-days. Number of shares sold short was 23.29 million shares which calculate 25.14 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $9.50 to the stock, which implies a rise of 52.95% to its current value. Analysts have been projecting $6.00 as a low price target for the stock while placing it at a high target of $13.00. It follows that stock’s current price would drop -190.83% in reaching the projected high whereas dropping to the targeted low would mean a loss of -34.23% for stock’s current value.
Sana Biotechnology Inc. (SANA) estimates and forecasts
Statistics highlight that Sana Biotechnology Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company added 37.12% of value to its shares in past 6 months, showing an annual growth rate of 2.21% while that of industry is 12.00. Apart from that, the company came raising its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to increase by 2.20% in the current quarter and calculating -10.50% decrease in the next quarter.
SANA Dividends
Sana Biotechnology Inc. is more likely to be releasing its next quarterly report between October 31 and November 06 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Sana Biotechnology Inc. (NASDAQ:SANA)’s Major holders
Insiders are in possession of 10.43% of company’s total shares while institution are holding 92.79 percent of that, with stock having share float percentage of 103.59%. Investors also watch the number of corporate investors in a company very closely, which is 92.79% institutions for Sana Biotechnology Inc. that are currently holding shares of the company. Flagship Pioneering Inc. is the top institutional holder at SANA for having 33.29 million shares of worth $148.81 million. And as of Jun 29, 2023, it was holding 16.90% of the company’s outstanding shares.
The second largest institutional holder is FMR, LLC, which was holding about 16.64 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.45% of outstanding shares, having a total worth of $74.4 million.
On the other hand, Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 2.97 million shares of worth $13.27 million or 1.51% of the total outstanding shares. The later fund manager was in possession of 2.92 million shares on Jul 30, 2023, making its stake of worth around $13.07 million in the company or a holder of 1.48% of company’s stock.
- Tags: NASDAQ:SANA, SANA, Sana Biotechnology Inc., SANA stock
